The Discounted Cash Flow (DCF) valuation of Creo Medical Group PLC (CREO.L) is (600.30) GBP. With the latest stock price at 10.25 GBP, the upside of Creo Medical Group PLC based on DCF is -5956.5%.
Based on the latest price of 10.25 GBP and our DCF valuation, Creo Medical Group PLC (CREO.L) is a sell. selling CREO.L stocks now will result in a potential gain of 5956.5%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 5.7% - 7.3% | 6.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (1,993.69) - (358.63) | (600.30) |
| Upside | -19550.6% - -3598.8% | -5956.5% |